UNIVERSITE DE NANTES;CHU DE NANTES - CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES;THE UNIVERSITY OF MELBOURNE
发明人:
ANTOINE ROQUILLY,KARIM ASEHNOUNE,JOSE VILLADANGOS
申请号：
US16631687
公开号：
US20200147177A1
申请日:
2018.07.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to Interleukin 12 (IL12) or derivative thereof for use in the treatment of secondary infection. The present invention also relates to pharmaceutical composition comprising Interleukin 12 (IL12) or derivative thereof for use in the treatment of secondary infection. The present invention finds application in the therapeutic and diagnostic medical technical fields.
